ENDRA Life Sciences Files Preliminary Prospectus for Share, Warrant Offering

MT Newswires Live
2025/07/09

ENDRA Life Sciences (NDRA) filed a preliminary prospectus Wednesday for its planned offering of 15.7 million common shares and pre-funded warrants to purchase up to the same number of shares.

The company said it granted the underwriter a 45-day option to purchase up to about 2.4 million additional common shares. ENDRA will also issue underwriter warrants to purchase up to 628,000 common shares.

ENDRA said the pricing is yet to be determined with the underwriter.

Shares of ENDRA were down more than 15% in recent Wednesday trading.

Price: 7.05, Change: -1.25, Percent Change: -15.06

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10